Veterinary Medicines

Butomidor 10 mg/ml Injektionslösung für Pferde, Hunde und Katzen

Authorised
  • Butorphanol tartrate
Download as PDF

Product identification

Medicine name:
Butomidor 10 mg/ml Injektionslösung für Pferde, Hunde und Katzen
Butomidor Vet. 10 mg/ml injektionsvæske, opløsning
Active substance:
  • Butorphanol tartrate
Target species:
  • Dog
  • Horse
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Butorphanol tartrate
    14.58
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        hour
  • Subcutaneous use
    • Cat
      • Meat and offal
        0
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AF01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 1 x 10 ml
  • Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 1 x 50 ml
  • Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 10 x 10 ml
  • Clear glass vials with bromobutyl rubber stoppers and aluminium caps. Package size: 5 x 10 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetviva Richter GmbH
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 59238
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0005/001
Concerned member states:
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Iceland
  • Ireland
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Portugal
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, INJEKTIONSVÆSKE, OPLØSNING 10 MG-ML)
Published on: 18/11/2024
Download